Studies show that the expression of DAP12 is increased in RA patients, and blocking DAP12 with a tumor necrosis factor (TNF) inhibitor could reduce the signaling and cytokine production (48, 49). This evidence concerns the gene TYROBP and rheumatoid arthritis.